Funding
Funding not disclosed
Founders
Product
Problem
Current methods for detecting marijuana impairment often rely on invasive bodily fluid tests that do not accurately reflect recent use or impairment levels. These tests can detect marijuana use days or weeks after consumption, failing to distinguish between on-the-job impairment and legal, off-duty use. This creates challenges for employers seeking to maintain workplace safety without infringing on employee rights.
Solution
This company is developing a breathalyzer device designed to detect recent marijuana use by analyzing biomarkers present in exhaled breath. The technology aims to provide a non-invasive method for identifying individuals who are currently impaired, offering a more accurate assessment of on-the-job impairment compared to traditional testing methods. By focusing on biomarkers that correlate with recent use, the device intends to help businesses maintain workplace safety while respecting legal off-duty consumption.
Target Audience
The primary target audience includes employers in safety-sensitive industries, law enforcement agencies, and workplace safety organizations seeking a reliable method for detecting recent marijuana impairment.
Features
- Breath-based analysis of biomarkers indicative of recent marijuana use
- Non-invasive and rapid testing procedure
- Portable device for on-site screening
- Data logging and reporting capabilities for compliance tracking